Evidence map›Paper›PMID 35053551›Full record

ArticleCancers2022

Distal Gastrectomy for Symptomatic Stage IV Gastric Cancer Contributes to Prognosis with Acceptable Safety Compared to Gastrojejunostomy.

Nobuaki Fujikuni, Kazuaki Tanabe, Minoru Hattori, Yuji Yamamoto, Hirofumi Tazawa, Kazuhiro Toyota, Noriaki Tokumoto, Ryuichi Hotta, Senichiro Yanagawa, Yoshihiro Saeki and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Clinical impact of gastrectomy in surgically proven stage IV gastric cancers: retrospective analysis from Korean multicenter dataset (PASS-META).Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 1 country.

Nobuaki FujikuniDepartment of Surgery, JA Onomichi General Hospital, Onomichi 7228508, Japan.
Kazuaki TanabeDepartment of Perioperative and Critical Care Management, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 7398511, Japan.
Minoru HattoriCenter for Medical Education Institute of Biomedical & Health Sciences, Hiroshima University, Hiroshima 7398511, Japan.
Yuji YamamotoDepartment of Gastroenterological Surgery, Hiroshima Prefectural Hospital, Hiroshima 7340004, Japan.
Hirofumi TazawaDepartment of Surgery, Kure Medical Center/Chugoku Cancer Center, Kure 7370023, Japan.
Kazuhiro ToyotaDepartment of Surgery, Hiroshima Memorial Hospital, Hiroshima 7300802, Japan.
Noriaki TokumotoDepartment of Gastroenterological Surgery, Hiroshima City Asa Citizens Hospital, Hiroshima 7308518, Japan.ORCID 0000-0001-8045-4878
Ryuichi HottaDepartment of Surgery, National Hospital Organization Higashihiroshima Medical Center, Higashihiroshima 7390041, Japan.
Senichiro YanagawaDepartment of Surgery, JA Onomichi General Hospital, Onomichi 7228508, Japan.
Yoshihiro SaekiDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 7398511, Japan.ORCID 0000-0001-9233-8807
Yoichi SugiyamaDepartment of Surgery, JA Hiroshima General Hospital, Hatsukaichi 7388503, Japan.ORCID 0000-0002-8063-3961
Masahiro IkedaDepartment of Surgery, Chuden Hospital, Hiroshima 7308562, Japan.
Masayuki ShishidaDepartment of Surgery, JR Hiroshima Hospital, Hiroshima 7320057, Japan.ORCID 0000-0002-5662-6817
Toshikatsu FukudaDepartment of Surgery, Chugoku Rosai Hospital, Kure 7370193, Japan.
Keisuke OkanoDepartment of Surgery, Miyoshi Central Hospital, Miyoshi 7288502, Japan.
Masahiro NishiharaDepartment of Surgery, Tsuchiya General Hospital, Hiroshima 7300811, Japan.
Hideki OhdanDepartment of Gastroenterological and Transplant Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 7398511, Japan.
On Behalf Of Hiroshima Surgical Study Group Of Clinical Oncology HiSCO
Hiroshima University · JPHiroshima General Hospital · JPOnomichi General Hospital · JPChubu Electric Power (Japan) · JPChugoku Rosai Hospital · JPHigashihiroshima Medical Center · JPHiroshima City Asa Citizens Hospital · JPHiroshima Prefectural Hospital · JPKure Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic prolongation effect of reduction surgery for asymptomatic stage IV gastric cancer (GC) is unfavorable; however, its prognostic effect for symptomatic stage IV GC remains unclear. We aimed to compare the prognosis of gastrectomy and gastrojejunostomy for symptomatic stage IV GC.

methodsThis multicenter retrospective study analyzed record-based data of patients undergoing palliative surgery for symptomatic stage IV GC in the middle or lower-third regions between January 2015 and December 2019. Patients were divided into distal gastrectomy and gastrojejunostomy groups. We compared clinicopathological features and outcomes after propensity score matching (PSM).

resultsAmong the 126 patients studied, 46 and 80 underwent distal gastrectomy and gastrojejunostomy, respectively. There was no difference in postoperative complications between the groups. Regarding prognostic factors, surgical procedures and postoperative chemotherapy were significantly different in multivariate analysis. Each group was further subdivided into groups with and without postoperative chemotherapy. After PSM, the data of 21 well-matched patients with postoperative chemotherapy and 8 without postoperative chemotherapy were evaluated. Overall survival was significantly longer in the distal gastrectomy group (

conclusionsDistal gastrectomy for symptomatic stage IV GC contributes to prognosis with acceptable safety compared to gastrojejunostomy.

Indexed as

distal gastrectomygastric cancergastrojejunostomypalliative surgerystage IV

Identifiers

PMID35053551
PMCPMC8773932
OpenAlexW4205757202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.